Raymond D. Pittard - 03 Jan 2023 Form 4 Insider Report for Trane Technologies plc (TT)

Signature
/s/ Evan M. Turtz, Attorney-in Fact
Issuer symbol
TT
Transactions as of
03 Jan 2023
Net transactions value
-$1,662,350
Form type
4
Filing time
05 Jan 2023, 17:28:57 UTC
Previous filing
03 Aug 2022
Next filing
03 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TT Ordinary Shares Options Exercise $1,500,812 +15,813 +18% $94.91 103,531 03 Jan 2023 Direct
transaction TT Ordinary Shares Options Exercise $756,963 +7,190 +6.9% $105.28 110,721 03 Jan 2023 Direct
transaction TT Ordinary Shares Sale $3,920,125 -23,003 -21% $170.42 87,718 03 Jan 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TT Stock Option (Right to Buy) Options Exercise $0 -15,813 -100% $0.000000* 0 03 Jan 2023 Ordinary Shares 15,813 $94.91 Direct F3
transaction TT Stock Option (Right to Buy) Options Exercise $0 -7,190 -67% $0.000000 3,595 03 Jan 2023 Ordinary Shares 7,190 $105.28 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction executed pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 6, 2022.
F2 This transaction was executed in multiple trades ranging from $169.055 to $171.58 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 The stock option vests in three (3) pro rata annual installments beginning on August 1, 2020.
F4 The stock option vests in three (3) pro rata annual installments beginning on March 9, 2021.